You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Sep 11, 2025

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
Published on: March 4, 2017
Weina Ke1, Rui He2, Mark A Jensen1
1Bioinformatics and Computational Science, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, Frederick, Maryland, USA.
Cancer nanotechnologies offer revolutionary diagnostic and treatment potential. This review explores caNanoLab, a data portal, and the use of Large Language Models (LLMs) to enhance cancer nanotechnology research and data sharing.
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: